AT247979T
Use of skin penetration enhancers and barrier disruption agents to enhance transcutaneous immune response
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
96 members in 14 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 7585098 | United States of America | P | |
| 7585698 | United States of America | P | |
| 9904128 | United States of America | W |
Members96
| Document | Office | Kind | |
|---|---|---|---|
| CA2272417A1 | Canada | A1 | |
| WO9820734A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU5265298A | Australia | A | |
| US5910306A | United States of America | A | |
| CA2321596A1 | Canada | A1 | |
| WO9943350A1 | World Intellectual Property Organization (WIPO) | A1 | |
| AU3311599A | Australia | A | |
| US5980898A | United States of America | A | |
| BR9712952A | Brazil | A | |
| CN1241906A | China | A | |
| IL129919D0 | Israel | D0 | |
| EP1014787A1 | European Patent Office (EPO) | A1 | |
| KR20000053306A | Republic of Korea | A | |
| CA2368655A1 | Canada | A1 | |
| WO0061184A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4188100A | Australia | A | |
| WO0074714A2 | World Intellectual Property Organization (WIPO) | A2 | |
| EP1061951A1 | European Patent Office (EPO) | A1 | |
| AU5315000A | Australia | A | |
| NZ335749A | New Zealand | A | |
| WO0061184A3 | World Intellectual Property Organization (WIPO) | A3 | |
| WO0074714A3 | World Intellectual Property Organization (WIPO) | A3 | |
| JP2001511115A | Japan | A | |
| BR9908278A | Brazil | A | |
| EP1165132A2 | European Patent Office (EPO) | A2 | |
| JP2002504522A | Japan | A | |
| AU744537B2 | Australia | B2 | |
| EP1014787A4 | European Patent Office (EPO) | A4 | |
| CA2272417C | Canada | C | |
| JP2003523937A | Japan | A | |
| EP1061951B1 | European Patent Office (EPO) | B1 | |
| AT247979TThis record | Austria | T | |
| ATE247979T1 | Austria | T1 | |
| DE69910743D1 | Germany | D1 | |
| EP1356821A2 | European Patent Office (EPO) | A2 | |
| EP1356823A2 | European Patent Office (EPO) | A2 | |
| EP1384403A1 | European Patent Office (EPO) | A1 | |
| US2004028727A1 | United States of America | A1 | |
| EP1356821A3 | European Patent Office (EPO) | A3 | |
| EP1356823A3 | European Patent Office (EPO) | A3 | |
| US2004047872A1 | United States of America | A1 | |
| DE69910743T2 | Germany | T2 | |
| EP1014787B1 | European Patent Office (EPO) | B1 | |
| AT274805T | Austria | T | |
| ATE274805T1 | Austria | T1 | |
| US6797276B1 | United States of America | B1 | |
| DE69730534D1 | Germany | D1 | |
| US2004258703A1 | United States of America | A1 | |
| EP1557177A1 | European Patent Office (EPO) | A1 | |
| DE69730534T2 | Germany | T2 | |
| KR100517028B1 | Republic of Korea | B1 | |
| US2005287157A1 | United States of America | A1 | |
| US2006002949A1 | United States of America | A1 | |
| US2006002959A1 | United States of America | A1 | |
| US7037499B1 | United States of America | B1 | |
| CN1279976C | China | C | |
| US2006269593A1 | United States of America | A1 | |
| EP1384403B1 | European Patent Office (EPO) | B1 | |
| AT349890T | Austria | T | |
| ATE349890T1 | Austria | T1 | |
| DE69737218D1 | Germany | D1 | |
| EP1356821B1 | European Patent Office (EPO) | B1 | |
| AT365050T | Austria | T | |
| ATE365050T1 | Austria | T1 | |
| CN101002727A | China | A | |
| DE69936355D1 | Germany | D1 | |
| EP1849477A1 | European Patent Office (EPO) | A1 | |
| DE69737218T2 | Germany | T2 | |
| ES2289200T3 | Spain | T3 | |
| DE69936355T2 | Germany | T2 | |
| US2008063696A1 | United States of America | A1 | |
| IL129919A | Israel | A | |
| US7378097B2 | United States of America | B2 | |
| US2008233142A1 | United States of America | A1 | |
| US2009081244A1 | United States of America | A1 | |
| JP2010059201A | Japan | A | |
| JP4584361B2 | Japan | B2 | |
| EP2272526A2 | European Patent Office (EPO) | A2 | |
| EP2286834A2 | European Patent Office (EPO) | A2 | |
| EP2368575A2 | European Patent Office (EPO) | A2 | |
| US2011243979A1 | United States of America | A1 | |
| EP1165132B1 | European Patent Office (EPO) | B1 | |
| EP2368575A3 | European Patent Office (EPO) | A3 | |
| AT529130T | Austria | T | |
| ATE529130T1 | Austria | T1 | |
| ES2372592T3 | Spain | T3 | |
| EP2286834A3 | European Patent Office (EPO) | A3 | |
| EP2272526A3 | European Patent Office (EPO) | A3 | |
| JP4875799B2 | Japan | B2 | |
| JP2012041355A | Japan | A | |
| JP4932086B2 | Japan | B2 | |
| CA2321596C | Canada | C | |
| US2012201845A1 | United States of America | A1 | |
| EP1356823B1 | European Patent Office (EPO) | B1 | |
| EP2368575B1 | European Patent Office (EPO) | B1 | |
| US8911742B2 | United States of America | B2 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 99936034
Titles2
- German
- VERWENDUNG VON HAUTPENETRATIONSFÖRDERERN UND FÜR DIE ZERSTÖRUNG DER OBEREN HAUTSCHICHTEN GEEIGNETEN MITTELN ZUR ERHÖHUNG DER DURCH ADP- RIBOSYLATING-EXOTOXIN INDUZIERTEN IMMUNANTWORT
- English
- USE OF SKIN PENETRATION CONVEYORS AND MEANS FOR THE DESTRUCTION OF THE UPPER CLOSURES TO INCREASE THE IMMUNE RESULT THAT IS INDUCED BY ADPROIBOSYLATING EXOTOXIN
Classification
- CPC, 15
- A61K47/10
- A61K9/0014
- A61K9/7023
- A61K39/00
- A61K39/39
- A61K47/08
- A61K47/12
- A61K2039/55522
- A61K2039/55544
- A61K2039/55561
- A61K2039/55572
- A61P37/00
- A61P37/02
- A61P37/04
- A61P43/00
- IPC, 11
- A61K39 00
- A61K39 39
- A61K47 08
- A61K47 10
- A61K47 12
- A61K9 00
- A61K9 70
- A61P37 02
- A61P37 04
- A61P43 00
- C12N15 09